Brad A. Winterstein
Papers
1
Total Citations
7
H-Index
1
About
Brad A. Winterstein is a leading clinical researcher in hernia surgery and surgical mesh technology, with a focus on improving outcomes in complex abdominal wall reconstruction. His key contributions center on evaluating bioabsorbable and long-term resorbable meshes to reduce surgical site occurrences (SSOs) in high-risk patients. Winterstein’s most cited work, the ATLAS trial (2021, 7 citations), is a prospective, multicenter study that assessed a novel bioabsorbable mesh with Sepra technology (P4HB-ST) in laparoscopic ventral or incisional hernia repair. This landmark trial specifically targeted patients with Class I (clean) wounds at elevated risk for SSOs, establishing a primary endpoint of SSOs requiring intervention within 45 days. By demonstrating the safety and efficacy of this advanced mesh in challenging repairs, Winterstein has provided critical evidence for reducing postoperative complications and improving patient recovery. His research bridges the gap between innovative biomaterials and real-world surgical practice, offering surgeons data-driven tools to manage high-risk hernias. Winterstein’s work continues to shape clinical guidelines and device development in hernia surgery, making him a key figure in advancing patient-centered outcomes in this field.
Research Focus
Key Achievements
Top Papers
- 1